Literature DB >> 9952281

Cytokines in the pathogenesis of systemic lupus erythematosus.

V R Kelley1, R P Wüthrich.   

Abstract

Cytokines, chemokines, and growth factors are overexpressed by renal parenchymal cells and by infiltrating mononuclear cells in human and experimental lupus nephritis. The importance of cytokines in the pathogenesis of lupus nephritis has been established using spontaneous mouse models of systemic lupus erythematosus (SLE). The actions of these cytokines are complex. There is a growing appreciation that the cytokine level and stage of kidney disease determines whether cytokine protects or promotes further tissue injury. This article identifies potential therapeutic targets and strategies that might halt progressive renal injury in patients with SLE.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9952281

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  28 in total

Review 1.  Can estrogens promote hypertension during systemic lupus erythematosus?

Authors:  Marcia Venegas-Pont; Michael J Ryan
Journal:  Steroids       Date:  2010-02-21       Impact factor: 2.668

Review 2.  T cells and B cells in lupus nephritis.

Authors:  Mary H Foster
Journal:  Semin Nephrol       Date:  2007-01       Impact factor: 5.299

3.  Association of interleukin (IL)-4 intron-3 and IL-6 -174 G/C gene polymorphism with susceptibility to end-stage renal disease.

Authors:  Rama Devi Mittal; Parmeet Kaur Manchanda
Journal:  Immunogenetics       Date:  2007-01-04       Impact factor: 2.846

4.  Targeted IgA Fc receptor I (FcαRI) therapy in the early intervention and treatment of pristane-induced lupus nephritis in mice.

Authors:  C Liu; Y Kanamaru; T Watanabe; N Tada; S Horikoshi; Y Suzuki; Z Liu; Y Tomino
Journal:  Clin Exp Immunol       Date:  2015-07-02       Impact factor: 4.330

5.  Modulation of the immune response in pristane-induced lupus by expression of activation and inhibitory Fc receptors.

Authors:  Raphael Clynes; Nicola Calvani; Byron P Croker; Hanno B Richards
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

6.  Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc.

Authors:  B R Lawson; G J Prud'homme; Y Chang; H A Gardner; J Kuan; D H Kono; A N Theofilopoulos
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

7.  Relationships between MMP-2, MMP-9, TIMP-1 and TIMP-2 levels and their pathogenesis in patients with lupus nephritis.

Authors:  Zhongxin Jiang; Tao Sui; Bin Wang
Journal:  Rheumatol Int       Date:  2009-09-25       Impact factor: 2.631

Review 8.  Cytokine overproduction, T-cell activation, and defective T-regulatory functions promote nephritis in systemic lupus erythematosus.

Authors:  Marco Tucci; Stefania Stucci; Sabino Strippoli; Francesco Silvestris
Journal:  J Biomed Biotechnol       Date:  2010-06-29

9.  Loss of LFA-1, but not Mac-1, protects MRL/MpJ-Fas(lpr) mice from autoimmune disease.

Authors:  Christopher G Kevil; M John Hicks; Xiaodong He; Junxuan Zhang; Christie M Ballantyne; Chander Raman; Trenton R Schoeb; Daniel C Bullard
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

10.  Up-regulation of IL-18 and predominance of a Th1 immune response is a hallmark of lupus nephritis.

Authors:  N Calvani; H B Richards; M Tucci; G Pannarale; F Silvestris
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.